The Weekly Litigation News Digest is now live. Subscribe now
Biomarkers For A Therapy Comprising A Sorafenib Compound - EP3861346
The patent EP3861346 was granted to Eisai R&D Management on Jan 8, 2025. The application was originally filed on Oct 2, 2019 under application number EP19790311A. The patent is currently recorded with a legal status of "Granted And Under Opposition".
EP3861346
- Application Number
- EP19790311A
- Filing Date
- Oct 2, 2019
- Status
- Granted And Under Opposition
- Dec 6, 2024
- Publication Date
- Jan 8, 2025
- External Links
- Slate, Register, Google Patents
Patent Summary
Patent Family
Patent Oppositions
Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Patent Citations (19) New
Patent citations refer to prior patents cited during different phases such as opposition or international search.
Dossier Documents
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents